(E/Z) -BCI

• Description :

  (E/Z) -BCI attenuates LPS-induced inflammatory mediators and ROS production in macrophage cells via activating the Nrf2 signaling axis and inhibiting the NF-κB pathway. (E/Z) -BCI is a dual-specificity phosphatase 6 (DUSP6) inhibitor with anti-inflammatory activities.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  317.432

• Molecular Formula :

  C22H23NO

• Notes :

  Research use only, not for human use.

• Receptor :

  PEGs

• CAS Number :

  15982-84-0